Abstract

ABSTRACTTissue-type plasminogen activator (t-PA) increases the risk of intracranial hemorrhage by gelatinase B (matrix metalloprotease-9; MMP-9) production in brain endothelial cells. It was recently reported that the free-radical scavenger edaravone significantly decreases t-PA-mediated MMP-9 production. Therefore, by using cultured brain endothelial cells (b.End3), we investigated whether t-PA-mediated MMP-9 production was enhanced by reactive oxygen species (ROS) and its signaling pathways. Moreover, we also investigated that whether this combined enhancement is reduced by edaravone. The b.End3 cells were exposed to t-PA (10 μg/mL), followed by H2O2 (30 μM); further, the MMP-9 protein level was measured. ROS enhanced MMP-9 production, and ROS plus t-PA significantly increased MMP-9 production more than t-PA or ROS alone. The results showed that H2O2 or t-PA alone caused a significant increase in NF-κB translocation to the nucleus, whereas the combination of t-PA and H2O2 increased the translocation of NF-κB to an even greater extent. Moreover, the combination of t-PA and ROS significantly increased I-κB degradation as well as NF-κB expression. Edaravone completely decreased the ROS plus t-PA-mediated MMP-9 enhancement. In conclusion, ROS enhanced t-PA-mediated MMP-9 production in brain endothelial cells; this MMP-9 production was decreased by the addition of edaravone, which inhibited the NF-κB pathway, specifically by enhancing I-κB degradation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.